Colin Hislop
2016 - Versartis
In 2016, Colin Hislop earned a total compensation of $1.7M as Chief Medical Officer at Versartis.
Compensation breakdown
| Bonus | $35,000 |
|---|---|
| Non-Equity Incentive Plan | $104,621 |
| Option Awards | $1,244,095 |
| Salary | $289,665 |
| Stock Awards | $60,100 |
| Other | $5,112 |
| Total | $1,738,593 |
Hislop received $1.2M in option awards, accounting for 72% of the total pay in 2016.
Hislop also received $35K in bonus, $104.6K in non-equity incentive plan, $289.7K in salary, $60.1K in stock awards and $5.1K in other compensation.
Rankings
In 2016, Colin Hislop's compensation ranked 5,541st out of 14,075 executives tracked by ExecPay. In other words, Hislop earned more than 60.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,541 out of 14,075 | 61st |
Division Manufacturing | 1,996 out of 5,489 | 64th |
Major group Chemicals And Allied Products | 637 out of 1,895 | 66th |
Industry group Drugs | 478 out of 1,538 | 69th |
Industry Pharmaceutical Preparations | 380 out of 1,176 | 68th |
Source: SEC filing on April 25, 2017.
Hislop's colleagues
We found two more compensation records of executives who worked with Colin Hislop at Versartis in 2016.